Vaxcyte, Inc. (PCVX)
65.02
-1.94
(-2.90%)
USD |
NASDAQ |
Oct 08, 16:00
65.01
0.00 (0.00%)
Pre-Market: 08:12
Vaxcyte Market Cap : 9.413B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 9.413B |
| October 07, 2026 | 9.695B |
| October 06, 2026 | 9.657B |
| October 05, 2026 | 10.69B |
| October 02, 2026 | 8.178B |
| October 01, 2026 | 8.115B |
| September 30, 2026 | 8.238B |
| September 29, 2026 | 8.208B |
| September 28, 2026 | 8.437B |
| September 25, 2026 | 8.138B |
| September 24, 2026 | 8.238B |
| September 23, 2026 | 8.180B |
| September 22, 2026 | 8.545B |
| September 21, 2026 | 8.531B |
| September 18, 2026 | 8.416B |
| September 17, 2026 | 8.741B |
| September 16, 2026 | 8.509B |
| September 15, 2026 | 8.573B |
| September 14, 2026 | 8.621B |
| September 11, 2026 | 8.610B |
| September 10, 2026 | 8.528B |
| September 09, 2026 | 8.616B |
| September 08, 2026 | 8.739B |
| September 04, 2026 | 8.855B |
| September 03, 2026 | 8.857B |
| Date | Value |
|---|---|
| September 02, 2026 | 8.916B |
| September 01, 2026 | 8.804B |
| August 31, 2026 | 8.794B |
| August 28, 2026 | 8.663B |
| August 27, 2026 | 8.854B |
| August 26, 2026 | 8.845B |
| August 25, 2026 | 8.845B |
| August 24, 2026 | 8.958B |
| August 21, 2026 | 9.066B |
| August 20, 2026 | 8.881B |
| August 19, 2026 | 9.165B |
| August 18, 2026 | 8.657B |
| August 17, 2026 | 8.719B |
| August 14, 2026 | 8.408B |
| August 13, 2026 | 8.522B |
| August 12, 2026 | 8.636B |
| August 11, 2026 | 8.574B |
| August 10, 2026 | 8.440B |
| August 07, 2026 | 8.408B |
| August 06, 2026 | 8.526B |
| August 05, 2026 | 8.096B |
| August 04, 2026 | 7.918B |
| August 03, 2026 | 7.750B |
| July 31, 2026 | 7.805B |
| July 30, 2026 | 8.076B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 78.60B |
| Arrowhead Pharmaceuticals, Inc. | 8.573B |
| Oncolytics Biotech, Inc. | 67.85M |
| Sangamo Therapeutics, Inc. | 58.04M |
| Sarepta Therapeutics, Inc. | 1.923B |
Market Cap Related Metrics
| PEG Ratio | -0.1005 |
| Price to Book Value | 3.413 |
| Price | 65.02 |
| Earnings Yield | -11.86% |
| PEGY Ratio | -0.1005 |